<DOC>
	<DOC>NCT00206141</DOC>
	<brief_summary>This study is being carried out to see if quetiapine fumarate (Seroquel) is effective in treating bipolar depression during an 8-week acute phase compared with placebo and lithium, followed by continuation treatment for 26 up to 52 with quetiapine fumarate (Seroquel) compared to placebo.</brief_summary>
	<brief_title>Seroquel in Bipolar Depression Versus Lithium</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patients with a diagnosis of bipolar I disorder or bipolar II disorder, currently depressed, aged 18 to 65 years old and outpatient status at enrolment and randomization. Patients with a current DSMIV Axis I disorder other than bipolar disorder that is symptomatic or requiring treatment within 6 months of enrolment, History of nonresponse to an adequate treatment Patients who, in the investigator's judgment pose a current serious suicidal or homicidal risk Pregnancy or lactation Clinically relevant disease or clinical finding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>bipolar depression</keyword>
	<keyword>depression</keyword>
</DOC>